Dietary 1,3-diacylglycerol protects against diet-induced obesity and insulin resistance

Metabolism: Clinical and Experimental

Volumn 56, Issue 11, 2007, Pages 1566-1575

  Saito, Shinichiro ^a   Hernandez Ono, Antonio ^a   Ginsberg, Henry N ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 DIACYLGLYCEROL; DIACYLGLYCEROL DERIVATIVE; LIPOPROTEIN LIPASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2; UNCOUPLING PROTEIN 3;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY FAT; CONTROLLED STUDY; DIET; GENE EXPRESSION; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; LIPID DIET; LIPID METABOLISM; LIVER METABOLISM; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; SKELETAL MUSCLE; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; BASE SEQUENCE; DIET; DIGLYCERIDES; DNA PRIMERS; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; MICE; OBESITY; POLYMERASE CHAIN REACTION;

EID: 35248867322     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.06.024     Document Type: Article

References (42)

1. Zimmet P., Alberti K.G., and Shaw J. Global and societal implications of the diabetes epidemic. Nature 13 (2001) 782-787
2. Nigro J., Osman N., Dart A.M., et al. Insulin resistance and atherosclerosis. Endocr Rev 27 (2006) 242-259
3. Behn A., and Ur E. The obesity epidemic and its cardiovascular consequences. Curr Opin Cardiol 21 (2006) 353-360
4. Hartz A.J., RupleyJr D.C., Kalkhoff R.D., et al. Relationship of obesity to diabetes: influence of obesity level and body fat distribution. Prev Med 12 (1983) 351-357
5. Younis N., Soran H., and Farook S. The prevention of type 2 diabetes mellitus: recent advances. QJM 97 (2004) 451-455
6. Reaven G.M., and Chen Y.-D. Role of insulin in regulation of lipoprotein metabolism in diabetes. Diabetes Metab Rev 4 (1988) 639-652
7. Anonymous expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the NCEP expert panel on detection, evaluation, and treatment of high cholesterol in adults (adult treatment panel III). JAMA 285-258 (2001) 2486-2497
8. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428
9. Yasukawa T., and Katsuragi Y. Diacylglycerols. In: Katsuragi Y., Yasukawa T., and Matsuo N. (Eds). Diacylglycerol oil (2004), AOCS Press 1-15
10. Taguchi H., Watanabe H., Onizawa K., et al. Double-blind controlled study on the effects of dietary diacylglycerol on postprandial serum and chylomicron triacylglycerol responses in healthy humans. J Am Coll Nutr 19 (2000) 789-796
11. Tada N., Watanabe H., Matsuo N., et al. Dynamics of postprandial remnant-like lipoprotein particles in serum after loading of diacylglycerols. Clin Chim Acta 311 (2002) 109-117
12. Maki K.C., Davidson M.H., Tsushimi R., et al. Consumption of diacylglycerol oil as part of a reduced-energy diet enhances loss of body weight and fat in comparison with consumption of a triacylglycerol control oil. Am J Clin Nutr 76 (2002) 1230-1236
13. Nagao T., Watanabe H., Goto N., et al. Dietary diacylglycerol suppress accumulation of body fat compared to triacylglycerol in men in a double-blind controlled trial. J Nutr 130 (2000) 792-797
14. Mori Y., Nakagiri H., Kondo H., et al. Dietary diacylglycerol reduces postprandial hyperlipidemia and ameliorates glucose intolerance in Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Nutrition 21 (2005) 933-939
15. Meguro S., Osaki N., Matsuo N., et al. Effect of diacylglycerol on the development of impaired glucose tolerance in sucrose-fed rats. Lipids 41 (2006) 347-355
16. Murata M., Hara K., and Ide T. Alteration by diacylglycerol of the transport of fatty acid composition of lymph chylomicrons in rats. Biosci Biotechnol Biochem 58 (1994) 1416-1419
17. Murase T., Mizuno T., Omachi T., Onizawa K., Komine Y., Kondo H., et al. Dietary diacylglycerol suppresses high fat and high sucrose diet-induced body fat accumulation in C57BL/6J mice. J Lipid Res 42 (2001) 372-378
18. Murase T., Aoki M., Wakisaka T., et al. Anti-obesity effect of dietary diacylglycerol in C57BL/6J mice: dietary diacylglycerol stimulates intestinal lipid metabolism. J Lipid Res 43 (2002) 1312-1319
19. Murata M., Ite T., and Hara K. Reciprocal responses to dietary diacylglycerol of hepatic enzymes of fatty acid synthesis and oxidation in the rat. Br J Nutr 77 (1997) 107-121
20. Yasunaga K., Saito S., Zhang Y.L., et al. Comparison of blood clearance, tissue uptake, and hepatic apoB secretion in mice receiving triacylglycerol and diacylglycerol emulsions either orally or intravenously. J Lipid Res 48 (2007) 1108-1121
21. Lowell B.B., Susulic V.S., Hamann A., et al. Development of obesity in transgenic mice following the genetic ablation of brown adipose tissue. Nature 366 (1993) 740-742
22. Siri P., Candela N., Ko C., et al. Post-transcriptional stimulation of the assembly and secretion of triglyceride-rich apolipoprotein B-lipoproteins in a mouse with selective deficiency of brown adipose tissue, obesity and insulin resistance. J Biol Chem 276 (2001) 46064-46072
23. Zhang Y.L., Hernandez-Ono A., Siri P., et al. Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis. J Biol Chem 281 (2006) 37603-37615
24. Watanabe T., Shimizu M., Sugiura M., et al. Optimization of reaction conditions for the production of DAG using immobilized 1,3-regiospecific lipase lipozyme RM IM. J Am Oil Chem Soc 80 (2003) 1201-1207
25. Taguchi H., Nagao T., Watanabe H., et al. Energy value and digestibility of dietary oil containing mainly 1,3-diacylglycerol are similar to those of triacylglycerol. Lipids 36 (2001) 379-382
26. Deckelbaum R.J., Hamilton J.A., Moser A., et al. Medium-chain versus long-chain triacylglycerol emulsion hydrolysis by lipoprotein lipase and hepatic lipase: implications for the mechanisms of lipase action. Biochemistry 29 (1990) 1136-1142
27. Folch J., Lees M., et al. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 224 (1957) 497-509
28. Carr T.P., Andresen C.J., and Rudel L.L. Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts. Clin Biochem 26 (1993) 39-42
29. Quinn P.G., and Yeagley D. Insulin regulation of PEPCK gene expression: a model for rapid and reversible modulation. Curr Drug Targets Immune Endocr Metabol Disord 5 (2005) 423-437
30. Hall R.K., Wang X.L., George L., et al. Insulin represses phosphoenolpyruvate carboxykinase gene transcription by causing the rapid disruption of an active transcription complex: a potential epigenetic effect. Mol Endocrinol 21 (2006) 550-563
31. Hotamisligil G.S., Arner P., Caro J.F., et al. Increased adipose expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95 (1995) 2409-2415
32. Hotamisligil G.S. Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord 27 (2003) S53-S55
33. Weisberg S.P., McCann D., Desai M., et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112 (2003) 1796-1808
34. Xu H., Barnes G.T., Yang Q., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112 (2003) 1821-1830
35. Kamei N., Tobe K., Suzuki R., et al. Overexpression of monocyte chemoattractant protein 1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 281 (2006) 26602-26614
36. Suganami T., Tanimoto-Koyama K., Nishida J., et al. Role of the toll-like reception 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 27 (2007) 84-91
37. Shi H., Kokoeva M.V., Inouye K., et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116 (2006) 3015-3025
38. Kern P.A., Saghizadeh M., Ong J.M., et al. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95 (1995) 2111-2119
39. Jellema A., Plat J., and Mensink R.P. Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state. Eur J Clin Invest 34 (2004) 766-773
40. Mela KamphuisD.J., and Wersterterp-Plantenga M.S. Diacylglycerol affect substrate oxidation and appetite in humans. Am J Clin Nutr 77 (2003) 1133-1139
41. Saito S., Tomonobu K., Hase T., et al. Effects of diacylglycerol on postprandial energy expenditure and respiratory quotient in healthy subjects. Nutrition 22 (2006) 30-35
42. Krauss S., Zhang C.Y., and Lowell B.B. The mitochondrial uncoupling-protein homologues. Nat Rev Mol Cell Biol 6 (2005) 248-261